Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Conditions
Kidney Diseases · Kidney Diseases, Chronic · Urological Diseases · Glomerulonephritis · Glomerular Disease · Glomerulonephritis, IGA · Glomerulopathy · Immunoglobulin Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Colorado Kidney Care Nephrology, Denver, Colorado, United States
Contact: Principal Investigator (Laura Kooienga)Nephrology Associates Of Central FL, Orlando, Florida, United States
Contact: Principal Investigator (Arvind Madan)NY Nephrology, Clifton Park, New York, United States
Contact: Principal Investigator (Frank Cortazar)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Kristin Meliambro)Knoxville Kidney Center Pllc, Brentwood, Tennessee, United States
Contact: Principal Investigator (George Newman)Dallas Renal Group, Dallas, Texas, United States
Contact: Principal Investigator (Phuong Truong)Dallas Renal Group, Dallas, Texas, United States
Contact: Principal Investigator (Irfan Agha)Nephro Asso North Illinois Indiana, Houston, Texas, United States
Contact: Principal Investigator (Suneel Udani)Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, La Plata, Buenos Aires, Argentina
Novartis Investigative Site, Buenos Aires, Buenos Aires F.D., Argentina
Novartis Investigative Site, Catamarca, Catamarca Province, Argentina
Novartis Investigative Site, Santa Fe, Argentina
Novartis Investigative Site, Kogarah, New South Wales, Australia
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Kuantan, Pahang, Malaysia
Novartis Investigative Site, Kuala Lumpur, Malaysia
Novartis Investigative Site, Cheonan, Chungcheongnam-do, South Korea
Novartis Investigative Site, Guri-si, Gyeonggi-do, South Korea
Novartis Investigative Site, Seongnam-si, Gyeonggi-do, South Korea
Novartis Investigative Site, Seoul, Seoul, South Korea
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals